Absorption of a mutagenic metabolite released from protein-bound residues of furazolidone
- 4 April 2002
- journal article
- Published by Elsevier in Environmental Toxicology and Pharmacology
- Vol. 11 (3-4) , 273-287
- https://doi.org/10.1016/s1382-6689(02)00013-3
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Depletion and Bioavailability of [14C]Furazolidone Residues in Swine TissuesJournal of Agricultural and Food Chemistry, 1995
- Depletion of protein‐bound furazolidone metabolites containing the 3‐amino‐2‐oxazolidinone side‐chain from liver, kidney and muscle tissues from pigsFood Additives & Contaminants, 1992
- Use of pig hepatocytes to study the inhibition of monoamine oxidase by furazolidoneFood and Chemical Toxicology, 1991
- The use of pig hepatocytes to study the nature of protein-bound metabolites of furazolidone: a new analytical method for their detectionFood and Chemical Toxicology, 1991
- The use of porcine hepatocytes for biotransformation studies of veterinary drugsXenobiotica, 1989
- Mutagenicity testing with the Salmonella/hepatocyte and the Salmonella/microsome assaysMutation Research/Genetic Toxicology, 1983
- Bovine liver dihydropyrimidine amidohydrolase: Purification, properties, and characterization as a zinc metalloenzymeArchives of Biochemistry and Biophysics, 1983
- INHIBITION OF MONOAMINE OXIDASE IN CHICKENS AND DUCKLINGS BY A MICROBIAL METABOLITE OF FURAZOLIDONEQuarterly Journal of Experimental Physiology, 1982
- INHIBITION OF MONOAMINE OXIDASE BY FURAZOLIDONE IN THE CHICKEN AND THE INFLUENCE OF THE ALIMENTARY FLORA THEREONBritish Journal of Pharmacology, 1980
- Cambendazole and nondrug macromolecules in tissue residuesJournal of Toxicology and Environmental Health, 1977